Artwork

Inhoud geleverd door Grant Stevens. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Grant Stevens of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.
Player FM - Podcast-app
Ga offline met de app Player FM !

Ep. 106 - Conor Gallagher on Building a Biotech Pipeline for Aesthetics and Therapeutics

38:43
 
Delen
 

Manage episode 436530056 series 3462066
Inhoud geleverd door Grant Stevens. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Grant Stevens of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.

As the Chief Scientific Officer at Revance, Conor Gallagher spearheads R&D, process and analytical development under the umbrella of scientific innovation while also leading a team working on Revance's biosimilar program.
With the stated goal of setting a "new standard in healthcare by elevating patient and physician experiences," Revance boasts an impressive lineup of aesthetic and therapeutic offerings. Notable among these are the RHA Collection of dermal fillers, designed to adapt to dynamic facial movements for natural-looking results, and Daxxify, a long-lasting/fast-acting neurotoxin for smoothing frown lines that is powered by a novel peptide. What's more, Daxxify was recently approved for FDA approved for the treatment of cervical dystonia in adults.
And the future is looking even brighter with the recent announcement that Revance has entered into a merger agreement with Crown Laboratories to bring together their complementary product lines to create a leading, innovative, high-growth aesthetics and skincare company.
So tune in for a sneak peek at what's next in the biotech pipeline at Revance — and soon to be Crown Laboratories — on the latest episode of The Technology of Beauty.

» Apple Podcasts | https://podcasts.apple.com/us/podcast/technology-of-beauty/id1510898426
» Spotify | https://open.spotify.com/show/0hEIiwccpZUUHuMhlyCOAm
» Recent episodes | https://www.influxmarketing.com/technology-of-beauty/
» Instagram | https://www.instagram.com/thetechnologyofbeauty/
» LinkedIn | https://www.linkedin.com/company/the-technology-of-beauty/
The Technology of Beauty is produced by Influx Marketing, The Digital Agency for Aesthetic Practices. https://www.influxmarketing.com/
Want more aesthetic insights? Subscribe to Next Level Practices, the show where we discuss the ever-changing world of digital marketing and patient acquisition and bring you the latest ideas, strategies, and tactics to help you take your practice to the next level. https://www.influxmarketing.com/next-level-practices/

  continue reading

104 afleveringen

Artwork
iconDelen
 
Manage episode 436530056 series 3462066
Inhoud geleverd door Grant Stevens. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Grant Stevens of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.

As the Chief Scientific Officer at Revance, Conor Gallagher spearheads R&D, process and analytical development under the umbrella of scientific innovation while also leading a team working on Revance's biosimilar program.
With the stated goal of setting a "new standard in healthcare by elevating patient and physician experiences," Revance boasts an impressive lineup of aesthetic and therapeutic offerings. Notable among these are the RHA Collection of dermal fillers, designed to adapt to dynamic facial movements for natural-looking results, and Daxxify, a long-lasting/fast-acting neurotoxin for smoothing frown lines that is powered by a novel peptide. What's more, Daxxify was recently approved for FDA approved for the treatment of cervical dystonia in adults.
And the future is looking even brighter with the recent announcement that Revance has entered into a merger agreement with Crown Laboratories to bring together their complementary product lines to create a leading, innovative, high-growth aesthetics and skincare company.
So tune in for a sneak peek at what's next in the biotech pipeline at Revance — and soon to be Crown Laboratories — on the latest episode of The Technology of Beauty.

» Apple Podcasts | https://podcasts.apple.com/us/podcast/technology-of-beauty/id1510898426
» Spotify | https://open.spotify.com/show/0hEIiwccpZUUHuMhlyCOAm
» Recent episodes | https://www.influxmarketing.com/technology-of-beauty/
» Instagram | https://www.instagram.com/thetechnologyofbeauty/
» LinkedIn | https://www.linkedin.com/company/the-technology-of-beauty/
The Technology of Beauty is produced by Influx Marketing, The Digital Agency for Aesthetic Practices. https://www.influxmarketing.com/
Want more aesthetic insights? Subscribe to Next Level Practices, the show where we discuss the ever-changing world of digital marketing and patient acquisition and bring you the latest ideas, strategies, and tactics to help you take your practice to the next level. https://www.influxmarketing.com/next-level-practices/

  continue reading

104 afleveringen

Minden epizód

×
 
Loading …

Welkom op Player FM!

Player FM scant het web op podcasts van hoge kwaliteit waarvan u nu kunt genieten. Het is de beste podcast-app en werkt op Android, iPhone en internet. Aanmelden om abonnementen op verschillende apparaten te synchroniseren.

 

Korte handleiding